PURE Bioscience, Inc.
PURE
$0.0688
$0.013825.09%
10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
---|---|---|---|---|---|
Revenue | -15.55% | 4.58% | 23.95% | 14.02% | 16.73% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -15.55% | 4.58% | 23.95% | 14.02% | 16.73% |
Cost of Revenue | -21.60% | -10.49% | -3.46% | 0.88% | 8.60% |
Gross Profit | -10.47% | 18.64% | 57.22% | 27.50% | 24.57% |
SG&A Expenses | -10.00% | -7.46% | -3.98% | -3.56% | 1.23% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -11.62% | -7.47% | -3.47% | -3.05% | 1.80% |
Operating Income | 9.13% | 13.70% | 15.65% | 11.42% | 5.84% |
Income Before Tax | 10.78% | 15.43% | 12.88% | 9.91% | -0.41% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 10.78% | 15.43% | 12.88% | 9.91% | -0.41% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 10.78% | 15.43% | 12.88% | 9.91% | -0.41% |
EBIT | 9.13% | 13.70% | 15.65% | 11.42% | 5.84% |
EBITDA | 10.22% | 15.04% | 15.54% | 10.66% | 4.35% |
EPS Basic | 10.81% | 15.45% | 17.88% | 18.81% | 14.40% |
Normalized Basic EPS | 4.23% | 9.80% | 17.41% | 18.78% | 20.25% |
EPS Diluted | 10.81% | 15.45% | 17.88% | 18.81% | 14.40% |
Normalized Diluted EPS | 4.23% | 9.80% | 17.41% | 18.78% | 20.25% |
Average Basic Shares Outstanding | 0.29% | 0.41% | 4.91% | 10.89% | 17.62% |
Average Diluted Shares Outstanding | 0.29% | 0.41% | 4.91% | 10.89% | 17.62% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |